SynAct Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:SYNACT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Mar 24	Buykr98,325	Thomas Boesen	Individual	14,250	kr6.90
21 Mar 24	Sellkr144,900	Thomas Boesen	Individual	21,000	kr6.90
16 Jun 23	Buykr77,761	Thomas Boesen	Individual	1,046	kr74.40

Insider Buying: SYNACT insiders have sold more shares than they have bought in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.8%.

Top 22 shareholders own 44.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.08%	Heights Capital Management, Inc.	3,750,000	kr25.0m	0%	1.31%
5.23%	TJ Biotech Invest ApS	2,161,225	kr14.4m	0%	no data
4.59%	Avanza Fonder AB	1,897,501	kr12.6m	0%	0.03%
4.11%	Nordnet AB (publ), Asset Management Arm	1,698,777	kr11.3m	-4.36%	0.15%
3.63%	Ryan Quinn	1,500,000	kr10.0m	0%	no data
3.32%	Quantass Invest Aps	1,370,419	kr9.1m	0%	no data
2.81%	Goodwind Holding Gmbh	1,161,777	kr7.7m	-0.01%	no data
2.73%	Thomas von Koch	1,126,641	kr7.5m	0%	no data
2.03%	Torbjorn Bjerke	838,547	kr5.6m	0%	no data
1.67%	Bioinvest Sverige Ab	688,670	kr4.6m	-81.7%	no data
0.79%	Handelsbanken Asset Management	326,133	kr2.2m	0%	no data
0.76%	SEB Investment Management AB	311,951	kr2.1m	0%	no data
0.72%	Robert Sahlin	296,485	kr2.0m	0%	no data
0.67%	Thomas Jonassen	274,725	kr1.8m	852%	no data
0.65%	Swedbank Försäkring AB, Asset Management Arm	266,836	kr1.8m	0%	0.39%
0.65%	Henrik Stage	266,836	kr1.8m	0%	no data
0.57%	Per Granath	237,188	kr1.6m	0%	no data
0.19%	FCG Fonder AB	77,770	kr517.6k	0%	0.02%
0.066%	Skandia Fonder AB	27,419	kr182.5k	0%	no data
0.033%	Jeppe Ovlesen	13,825	kr92.0k	8.58%	no data
0.0054%	Storebrand Fonder AB,	2,227	kr14.8k	0%	no data
0.0013%	State Street Global Advisors, Inc.	515	kr3.4k	12.2%	no data